These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25426656)

  • 21. Multiparametric MRI in the Diagnosis of Prostate Cancer: Physical Foundations, Limitations, and Prospective Advances of Diffusion-Weighted MRI.
    Wichtmann BD; Zöllner FG; Attenberger UI; Schönberg SO
    Rofo; 2021 Apr; 193(4):399-409. PubMed ID: 33302312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of diffusional kurtosis tensor imaging in prostate MRI for the assessment of prostate cancer: preliminary results.
    Quentin M; Pentang G; Schimmöller L; Kott O; Müller-Lutz A; Blondin D; Arsov C; Hiester A; Rabenalt R; Wittsack HJ
    Magn Reson Imaging; 2014 Sep; 32(7):880-5. PubMed ID: 24848289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer: correlation of intravoxel incoherent motion MR parameters with Gleason score.
    Yang DM; Kim HC; Kim SW; Jahng GH; Won KY; Lim SJ; Oh JH
    Clin Imaging; 2016; 40(3):445-50. PubMed ID: 27133684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
    Chen Z; Xue Y; Zhang Z; Li W; Wen M; Zhao Y; Li J; Weng Z; Ye Q
    Eur J Radiol; 2020 Apr; 125():108865. PubMed ID: 32058895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative evaluation of pelvine lymph node metastasis in high risk prostate cancer with intravoxel incoherent motion (IVIM) MRI.
    Sauer M; Klene C; Kaul M; Quitzke A; Avanesov M; Behzadi C; Budäus L; Beyersdorff D; Adam G; Regier M
    Eur J Radiol; 2018 Oct; 107():1-6. PubMed ID: 30292252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-Dependent Diffusion in Prostate Cancer.
    Lemberskiy G; Rosenkrantz AB; Veraart J; Taneja SS; Novikov DS; Fieremans E
    Invest Radiol; 2017 Jul; 52(7):405-411. PubMed ID: 28187006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravoxel Incoherent Motion (IVIM) Diffusion Weighted Imaging (DWI) in the Periferic Prostate Cancer Detection and Stratification.
    Pesapane F; Patella F; Fumarola EM; Panella S; Ierardi AM; Pompili GG; Franceschelli G; Angileri SA; Magenta Biasina A; Carrafiello G
    Med Oncol; 2017 Mar; 34(3):35. PubMed ID: 28144814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triexponential function analysis of diffusion-weighted MRI for diagnosing prostate cancer.
    Ueda Y; Takahashi S; Ohno N; Kyotani K; Kawamitu H; Miyati T; Aoyama N; Ueno Y; Kitajima K; Kawakami F; Okuaki T; Tsukamoto R; Yanagita E; Sugimura K
    J Magn Reson Imaging; 2016 Jan; 43(1):138-48. PubMed ID: 26119033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VERDICT-AMICO: Ultrafast fitting algorithm for non-invasive prostate microstructure characterization.
    Bonet-Carne E; Johnston E; Daducci A; Jacobs JG; Freeman A; Atkinson D; Hawkes DJ; Punwani S; Alexander DC; Panagiotaki E
    NMR Biomed; 2019 Jan; 32(1):e4019. PubMed ID: 30378195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
    Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
    Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefacts.
    Singh S; Giganti F; Dickinson L; Rogers H; Kanber B; Clemente J; Pye H; Heavey S; Stopka-Farooqui U; Johnston EW; Moore CM; Freeman A; Whitaker HC; Alexander DC; Panagiotaki E; Punwani S
    Eur J Radiol; 2023 Nov; 168():111109. PubMed ID: 37769532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
    Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
    AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of fitting models for prostate tissue characterization using extended-range b-factor diffusion-weighted imaging.
    Langkilde F; Kobus T; Fedorov A; Dunne R; Tempany C; Mulkern RV; Maier SE
    Magn Reson Med; 2018 Apr; 79(4):2346-2358. PubMed ID: 28718517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of diffusion-weighted magnetic resonance imaging to distinguish between lung cancer and focal inflammatory lesions: a comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.
    Deng Y; Li X; Lei Y; Liang C; Liu Z
    Acta Radiol; 2016 Nov; 57(11):1310-1317. PubMed ID: 25972370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging.
    Döpfert J; Lemke A; Weidner A; Schad LR
    Magn Reson Imaging; 2011 Oct; 29(8):1053-8. PubMed ID: 21855241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apparent diffusion coefficient and intravoxel incoherent motion-diffusion kurtosis model parameters in invasive breast cancer: Correlation with the histological parameters of whole-slide imaging.
    Mori N; Inoue C; Tamura H; Nagasaka T; Ren H; Sato S; Mori Y; Miyashita M; Mugikura S; Takase K
    Magn Reson Imaging; 2022 Jul; 90():53-60. PubMed ID: 35439547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ssVERDICT: Self-supervised VERDICT-MRI for enhanced prostate tumor characterization.
    Sen S; Singh S; Pye H; Moore CM; Whitaker HC; Punwani S; Atkinson D; Panagiotaki E; Slator PJ
    Magn Reson Med; 2024 Nov; 92(5):2181-2192. PubMed ID: 38852195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VERDICT MRI for radiation treatment response assessment in neuroendocrine tumors.
    Lundholm L; Montelius M; Jalnefjord O; Forssell-Aronsson E; Ljungberg M
    NMR Biomed; 2022 Jun; 35(6):e4680. PubMed ID: 34957637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of Gaussian and non-Gaussian diffusion models for differential diagnosis of prostate cancer with in-bore transrectal MR-guided biopsy as a pathological reference.
    Li C; Chen M; Wan B; Yu J; Liu M; Zhang W; Wang J
    Acta Radiol; 2018 Nov; 59(11):1395-1402. PubMed ID: 29486596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer.
    Shinmoto H; Tamura C; Soga S; Shiomi E; Yoshihara N; Kaji T; Mulkern RV
    AJR Am J Roentgenol; 2012 Oct; 199(4):W496-500. PubMed ID: 22997399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.